Significant Effect of Anti-tyrosine Kinase Inhibitor (Gefitinib) on Overall Survival of the Glioblastoma Multiforme Patients in the Backdrop of Mutational Status of Epidermal Growth Factor Receptor and PTEN Genes

INTRODUCTION: We aimed to assess the effect of anti-tyrosine kinase inhibitors (TKIs) (gefitinib) in overall survival (OS) of the glioblastoma multiforme (GBM) patients in the backdrop of mutational status of epidermal growth factor receptor (EGFR) and PTEN genes. MATERIALS AND METHODS: All the pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Arif, Sajad Hussain, Pandith, Arshad Ahmad, Tabasum, Rehana, Ramzan, Altaf Umar, Singh, Sarabjeet, Siddiqi, Mushtaq Ahmad, Bhat, Abdul Rashid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820893/
https://www.ncbi.nlm.nih.gov/pubmed/29492119
http://dx.doi.org/10.4103/ajns.AJNS_95_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820893/
https://www.ncbi.nlm.nih.gov/pubmed/29492119
http://dx.doi.org/10.4103/ajns.AJNS_95_17

Ejemplares similares